Clinical Medicine IV: Shock Fundamentals
Definition and Fundamental Pathophysiology of Shock
Definition of Shock: A life-threatening condition characterized by circulatory failure that leads to inadequate delivery of oxygen to meet cellular and metabolic needs and oxygen consumption requirements. * Core Result: Cellular and tissue hypoxia, which, if not corrected, ultimately results in death. * Progression: Initially, shock is a reversible state, but it rapidly progresses to an irreversible stage if the inciting event is not addressed. * Initial Inciting Events: * Injury or trauma. * Infection (e.g., sepsis, toxic shock syndrome). * Illness (e.g., Acute Myocardial Infarction (AMI), Pulmonary Embolism (PE), Gastrointestinal (GI) bleed).
The Fundamental Defect: Reduced perfusion of vital tissues.
Direct Pathophysiological Sequence: 1. Perfusion declines at the tissue level. 2. Oxygen levels drop to a point inadequate for aerobic metabolism. 3. Cells shift from aerobic to anaerobic metabolism. 4. Anaerobic metabolism lead to an increased production of . 5. Anaerobic metabolism of glucose leads to an accumulation of lactic acid (lactate). 6. Cellular function declines, eventually resulting in irreversible cell damage and death.
Systemic Inflammatory and Clotting Cascades
Triggering Peripheral Response: Hypoperfusion leads to hypoxemia, which triggers inflammatory and clotting cascades.
Endothelial Activation: Hypoxic vascular endothelial cells activate White Blood Cells (WBCs). These WBCs bind to the endothelium and produce various inflammatory mediators and enzymes.
Nitric Oxide (NO) and Cytokines: Activation leads to the release of cytokines and Nitric Oxide. * Nitric Oxide Impact: NO is a potent vasodilator. Its release results in hypotension, leading to "relative hypovolemia." * Abnormal Perfusion: Vasodilation shunts blood past capital beds, further disrupting normal tissue perfusion.
Disseminated Intravascular Coagulation (DIC): Clotting cascades are affected by intravascular damage during cellular hypoxia, leading to abnormal thrombosis and hemorrhage. * Clinical Presentation of DIC: * Bleeding or oozing from trauma sites, drains, or catheters. * Flat petechiae and ecchymosis. * Febrile/toxic appearance. * Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE). * Arterial thrombosis. * Laboratory Findings for DIC: * Thrombocytopenia (low platelets). * Prolonged PT/PTT/INR. * Elevated D-dimer.
Clinical Presentation and Physiological Compensation
Early Shock (Pre-shock): Compensatory mechanisms remain intact. * Oxygen Extraction: Tissues attempt to extract a greater percentage of the delivered oxygen because total delivery is decreased. * Sympathetic Tone: Carotid baroreceptors detect decreased blood pressure and trigger sympathetic responses to maintain Cardiac Output (). * Hormonal Response: Increased endogenous epinephrine and norepinephrine increase heart contractility. Adrenals release corticosteroids, kidneys release renin, and the liver releases glucose. * Selective Vasoconstriction: Initial vasoconstriction shunts blood preferentially to the heart and the brain. * Vital Signs in Early Shock: Heart rate () increases (tachycardia) to compensate. Blood pressure may remain normal or even elevated; this state is sometimes referred to as "cryptic shock."
Progressive Shock Findings: * Third-spacing (fluid leaking from damaged, leaky vessels). * Variable heart rate (tachycardia or bradycardia). * Altered mentation. * Hypothermia or hyperthermia. * Hypoglycemia. * Tachypnea and dyspnea. * Cool, clammy skin.
End-Stage Shock: Cellular death leads to irreversible multi-organ failure. * Renal failure. * Obtunded state or coma. * Death.
Mean Arterial Pressure (MAP) and Cardinal Signs
Mean Arterial Pressure (MAP): A measure of the average arterial pressure throughout the cardiac cycle, influenced by cardiac output and systemic vascular resistance (). * Estimation Formula: * Pulse Pressure: Defined as . * Perfusion Threshold: A MAP > 60 ext{ }mmHg is necessary to maintain adequate tissue perfusion.
Cardinal Signs of Shock: * Arterial Hypotension: Systolic Blood Pressure () < 90 ext{ }mmHg. * Skin Changes: Cool, clammy, and/or dusky skin. * Oliguria: Reduced urine output due to the shunting of renal blood flow. * Mental Status: Changes in mental status (confusion, delirium). * Metabolic Acidosis/Elevated Lactate: Lactate is a marker for systemic hypoperfusion and cellular dysfunction. * Lactate levels > 4 ext{ }mmol/L are associated with a 5x increase in risk of death (approximately mortality rate).
Evaluation: History and Physical Examination
History Taking: Review medical records. Shock may be apparent (e.g., trauma, hemorrhage, anaphylaxis, MI) or subtle (weakness, n/v/d, lethargy, fever). * Medication Interference: Diuretics may exacerbate hypovolemia. -blockers can blunt the compensatory tachycardia response in early shock.
Physical Examination (ABC Focus): * Airway, Breathing, Circulation: Initial priority. * Vital Signs: Monitor for fever/hypothermia, tachycardia/bradycardia, and hypertension/hypotension. * Cardiovascular (CV): * Neck vein distention (suggests cardiogenic/obstructive) or flattening (suggests hypovolemic). * Third heart sound (), which may be accentuated in high-output states. * Pulmonary: Listen for rales or crackles, which can indicate pulmonary edema due to Acute Respiratory Distress Syndrome (ARDS). * Abdominal: Check for tenderness, distention, or ileus (indicated by decreased bowel sounds). * GU/Perineum: Check for sources of GI bleeding. * Neurologic: Assess for restlessness, confusion, delirium, syncope, or coma. * Integumentary/Extremities: * Check for delayed capillary refill or skin mottling. * Assess skin for warmth, swelling, redness, color changes, and rashes.
Diagnostic Labs and Imaging
Laboratory Evaluation: * CBC: Monitor for low platelets (thrombocytopenia), high or low WBC count, and low Hgb/Hct. * BMP: Monitor for high or low glucose (hyperglycemia/hypoglycemia), elevated BUN/creatinine (indicating renal strain), and hyperkalemia. * Acid-Base Status: Early shock typically presents with respiratory alkalosis; late shock presents with metabolic acidosis and elevated lactate. * Coagulation: PT/INR (> 1.5), PTT, and elevated D-dimer. * Infection Markers: Procalcitonin (released early in response to bacterial infection; helps guide antibiotic efficacy but is not generally helpful for all sepsis) and CRP (> 2 standard deviations above normal). * Organ Function/Damage: Elevated LFTs and cardiac enzymes. * Cultures: UA/Urine culture and two sets of blood cultures (must be obtained prior to starting antibiotics). * Other: Pregnancy test, Type and Cross Match for blood units.
Imaging and Diagnostics: * ECG: Assess for dysrhythmias or underlying pathology (e.g., MI). * Chest X-ray: Check for pulmonary edema or other pathology. * Ultrasound (US): Echo and IVC ultrasound are used to assess volume status. * CT: Utilized as dictated by the patient's specific history.
Classification of Shock Types
Hypovolemic Shock: Caused by low circulatory (intravascular) volume. * Mechanism: Decreased fluid/blood volume leads to decreased pre-load, which decreases ventricular filling, stroke volume, and cardiac output. This results in primary compensatory vasoconstriction. * Hemorrhagic Causes: Trauma, surgery, GI Bleed (PUD, varices), aortic aneurysm rupture, obstetric hemorrhage (uterine atony), or ENT hemorrhage. * Non-Hemorrhagic Causes: Burns (thermal/chemical), vomiting, diarrhea, excessive sweating, potent diuretics, avascular tubular necrosis, and "third spacing" (ascites, pleural edema).
Cardiogenic Shock: The failure of the left ventricle to deliver oxygenated blood due to pump failure. * Characteristics: Pure cardiogenic shock has adequate intravascular volume but poor pump function. It is the leading cause of in-hospital death in patients with STEMI. * Etiology: Myocardial Infarction (#1 cause), dysrhythmias, valvular disease, or heart failure.
Obstructive Shock: Result of a physical (extra-cardiac) obstruction to blood flow. * Heart-level Obstructions: Pericardial tamponade, tension pneumothorax. * Vascular-level Obstructions: Pulmonary embolism (PE).
Distributive Shock: Caused by marked arterial or venous vasodilation with normal circulating blood volume. * Septic Shock: Most common type; life-threatening organ dysfunction caused by a dysregulated host response to infection. * Diagnosis: Sepsis-induced hypotension despite fluid resuscitation plus perfusion abnormalities (oliguria, lactic acidosis, altered mental status). * Mortality: . * Triggers: Pneumonia is the most common cause. Gram-negative bacteria are most common in ICU populations. * Neurogenic Shock: Typically due to spinal cord injury above (trauma). * Mechanism: Loss of sympathetic resistance and unopposed parasympathetic response. Results in vasodilation (skin is pink, warm, and dry), hypotension (< 90 ext{ }mmHg), and relative bradycardia (< 80 ext{ }bpm). * Other causes: Epidural injection, Guillain-Barr, toxins, transverse myelitis. * Anaphylactic Shock: Acute IgE-mediated reaction (stings, food, meds). * Clinical Presentation: Hives, pruritis, swelling of face/tongue, stridor, wheezing, abdominal cramps. * Note: of fatalities occur in the first hour. have biphasic reactions. * Adrenal Insufficiency and Pancreatitis: Other potential distributive causes.
Diagnosis Scoring Systems for Sepsis
SIRS (Septic Inflammatory Response Syndrome): Largely unused but still supported by CMS. * Criteria: Temp > 38^{\circ}C or < 36^{\circ}C ( or ); HR > 90, Respiratory Rate () > 20; WBC > 12,000 ext{ }cu/mm or < 4,000 ext{ }cu/mm (+ > 10\% bands).
NEWS (National Early Warning Score): * Measures: RR, Oxygen saturation, Systolic BP, Pulse, Consciousness level/confusion, and Temperature. * Scoring: (Low risk), (Medium risk).
qSOFA (Quick Sequential Organ Failure Assessment): Estimating risk in the ED (1 point each). * Indicators: Altered Mental Status (GCS < 13), RR > 22 ext{ }breaths/min, Systolic BP < 100 ext{ }mmHg. * Interpretation: Score of or suggests poor outcome and potential ICU admission.
SOFA Score: Used in the ICU to measure 6 parameters: respiratory, CV, hepatic, coagulation, renal, and neurologic. * An increase of > 2 points in a patient with infection is diagnostic of infection and prognosticates a mortality rate.
General and Specific Treatment Protocols
General Resuscitation: * Stabilize Airway and Breathing: Supplemental oxygen or intubation to maintain sat > 90\%. * Fluid Resuscitation: Crystalloids (0.9 Normal Saline or Lactated Ringers) with a bolus of of ideal body weight to maintain SBP > 100 ext{ }mmHg. * Vasoactive Medications: Norepinephrine to maintain MAP > 65 ext{ }mmHg. * Monitor: Repeat lactate levels every .
Treatment by Shock Type: * Hypovolemic Shock: * Two large-bore IVs or central line. * Trendelenburg position. * Crystalloid replacement (); PRBCs if bleeding. * Pressors (Norepinephrine/Vasopressin) as needed. * Cardiogenic Shock: * Follow ACLS protocol. * Crystalloids only if no pulmonary edema. * Inotropes (Dobutamine). * Early revascularization (PCI/CABG) for STEMI; Intra-aortic balloon pump. * Obstructive Shock: * PE: Thrombolysis. * Limited fluid replacement (excessive fluids may worsen hypotension). * Pressors (Norepinephrine). * Septic Shock: * Empiric antibiotics within . * Norepinephrine. * Anaphylactic Shock: * IM Epinephrine (First line). * Crystalloid resuscitation (). * IV Antihistamines and IV Corticosteroids. * Nebulized albuterol.